ArticleLeukemia2023

Correction: Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.

Ji-Nuo Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.